Clinical data | |
---|---|
Other names | 1-Cyclopropylmethylclonazepam, Kloniprazepam, 2-Chloro-7'-nitroprazepam |
Drug class | Benzodiazepines |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C19H16ClN3O3 |
Molar mass | 369.81 g·mol−1 |
3D model (JSmol) | |
| |
|
Cloniprazepam is a benzodiazepine derivative and a prodrug of clonazepam, 7-aminoclonazepam, and other metabolites.[1][2]
Some of the minor metabolites include 3-hydroxyclonazepam and 6-hydroxyclonazepam, 3-hydroxycloniprazepam and ketocloniprazepam with ketone group formed where 3-hydroxy group was.[1]
It is a designer drug and an NPS (short for "new psychoactive substance").[1] At the end of 2017, cloniprazepam was an uncontrolled substance in most of the countries.